Dose Increases and Medication Alternatives When Progress Stalls If you have maintained consistent healthy habits and a plateau persists beyond eight weeks, your prescriber may recommend a dose increase within the approved therapeutic range
Your healthcare team should establish a monitoring schedule that includes assessment of both physical health markers (weight, blood glucose, blood pressure, lipid profile) and mental health indicators (mood stability, sleep quality, medication adherence)
Other preliminary work from our group found that relatively higher TA levels predicted poorer response to SSRIs in MDD 43 , which was replicated in a more recent study 44
She called the drug "life-changing." Under-fuelling It could come at a risk, however, because the drugs reduce appetite, which means cyclists may not be able to fuel adequately and be in a low-energy deficit
For more information, see the How is NovoLog given? section
Studies have used MT-II alongside MC4R-selective agonists and MC4R knockout models to attribute the anorectic component of MT-IIs biology specifically to MC4R rather than MC3R activation
